Oxford Nanopore Technologies plc

Equities

ONT

GB00BP6S8Z30

Advanced Medical Equipment & Technology

Real-time Estimate Cboe Europe Other stock markets 02:37:00 18/07/2024 pm IST			5-day change	1st Jan Change
113.9 ^GBX	+3.45%		+7.58%	-45.23%

04/07	HSBC raises Bunzl to 'buy'; RBC likes Ibstock	AN
12/06	Oxford Nanopore Technologies plc Announces Termination of Wendy Mira Becker as Director	CI

Oxford Nanopore Technologies plc Provides Revenue Guidance for the Year Ended 31 December 2022

January 17, 2023 at 12:30 pm IST

Oxford Nanopore Technologies plc provided revenue guidance for the year ended 31 December 2022. The Group expects to report total revenue of approximately £199 million, for the year ended 31 December 2022.

Latest news about Oxford Nanopore Technologies plc

HSBC raises Bunzl to 'buy'; RBC likes Ibstock	04/07	AN
Oxford Nanopore Technologies plc Announces Termination of Wendy Mira Becker as Director	12/06	CI
Oxford Nanopore Technologies plc Announces Termination of James Willcocks as Director	12/06	CI
Oxford Nanopore Technologies plc Announces Changes to Director	10/06	CI
Oxford Nanopore Technologies plc Provides Updates to its Clinical Product Pipeline	23/05	CI
Oxford Nanopore Technologies Collaborates with Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine	22/05	CI
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	03/05	AN
Jefferies raises B&M to 'hold'	22/04	AN
EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises	02/04	AN
Kepler Cheuvreux likes Diageo; BofA lifts Man	14/03	AN
IP Group net asset value declines amid supply chain issues, inflation	13/03	AN
Transcript : Oxford Nanopore Technologies plc Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 09:00 AM	12/03
Oxford Nanopore Technologies Launches PromethION 2 Integrated into Open Early Access	07/03	CI
Good signals from central banks	07/03
Oxford Nanopore Technologies top team buys shares	07/03	AN
ANALYST RECOMMENDATIONS : AMD, Micron Technology, Snowflake, Zoom, Okta...	07/03
ITV, LondonMetric, Man, Domino's get upgrades	07/03	AN
What’s happening to the US economy?	06/03
Oxford Nanopore confident in future opportunities despite weak 2023	06/03	AN
ANALYST RECOMMENDATIONS : Crowdstrike, Target, Antofagasta, Direct Line Insurance, Premier Foods...	06/03
Shares rise in London ahead of budget	06/03
Oxford Nanopore Technologies' FY23 Loss Widens; Revenue Falls	06/03	MT
Transcript : Oxford Nanopore Technologies plc, Q4 2023 Earnings Call, Mar 06, 2024	06/03
ConvaTec profit doubles; DS smith trades in line	06/03	AN
Earnings Flash (ONT.L) OXFORD NANOPORE TECHNOLOGIES Reports FY23 Revenue GBP169.7M	06/03	MT

Chart Oxford Nanopore Technologies plc

Duration

Period

More charts

Company Profile

Oxford Nanopore Technologies plc is engaged in the generation of molecular sensing technology based on nanopores. The Company has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. The Companyâs segments include Life Science Research Tools, which offers products and services for research use, and COVID Testing, which provides products for SAR-Cov-2 testing. Its sequencing technology offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Its products include MinION, GridION, PromethION, Flongle and others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five MinION or Flongle Flow Cells. Flongle is an adapter for MinION or GridION that enables direct, real-time DNA sequencing, or cDNA sequencing on smaller, single-use flow cells.

Sector

Advanced Medical Equipment & Technology

Calendar

24/07/2024 - Q2 2024 Sales and Revenue Release - Trading Update

More about the company

Income Statement Evolution

More financial data

Ratings for Oxford Nanopore Technologies plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.101 GBP

Average target price

1.819 GBP

Spread / Average Target

+65.20%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OXFORD NANOPORE TECHNOLOGIES PLC	-45.23%	125.14Cr
THERMO FISHER SCIENTIFIC	+4.57%	21TCr
DANAHER CORPORATION	+8.61%	19TCr
INTUITIVE SURGICAL, INC.	+26.34%	15TCr
BOSTON SCIENTIFIC CORPORATION	+33.90%	11TCr
SIEMENS HEALTHINEERS AG	+3.38%	6.56TCr
EDWARDS LIFESCIENCES CORPORATION	+14.50%	5.26TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	4.68TCr
AGILENT TECHNOLOGIES, INC.	-3.98%	3.9TCr
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	3.76TCr

Other Advanced Medical Equipment & Technology